Colfax Corporation (CFXA)
NYSE: CFXA
· Real-Time Price · USD
177.71
-2.39 (-1.33%)
At close: Apr 24, 2025, 3:47 PM
Colfax Revenue Breakdown
| Period Ending | Oct 1, 2021 | Jul 2, 2021 | Apr 2, 2021 | Dec 31, 2020 | Oct 2, 2020 | Jul 3, 2020 | Apr 3, 2020 | Mar 29, 2019 |
|---|---|---|---|---|---|---|---|---|
| Fabrication Technology Revenue | 1.82B | 1.89B | 1.7B | n/a | 1.47B | 1.24B | 1.58B | 1.68B |
| Fabrication Technology Revenue Growth | -3.78% | +10.86% | n/a | -100.00% | +18.61% | -21.15% | -6.22% | n/a |
| Medical Technology Revenue | 1.08B | 1.07B | 933.25M | n/a | 943.3M | 617.98M | 872.46M | 370.61M |
| Medical Technology Revenue Growth | +1.07% | +14.48% | n/a | -100.00% | +52.64% | -29.17% | +135.41% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2021 | Oct 1, 2021 | Jul 2, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 351.67M | 334.42M | 337.56M | 305.72M | 281.42M | 278.06M | 235.73M | 291.3M | 285.86M | 290.5M | 307.94M | 318.14M | 218.07M | 194.83M | 204.78M | 200.52M | 198.79M | 181.84M | 208.22M | 206.05M | 197.8M | 199.5M | 213.55M | 214.39M | 232.84M | 237.25M | 222.63M | 213.23M |
| Selling, General, and Administrative Revenue Growth | +5.16% | -0.93% | +10.41% | +8.64% | +1.21% | +17.96% | -19.08% | +1.90% | -1.60% | -5.66% | -3.21% | +45.89% | +11.93% | -4.86% | +2.13% | +0.87% | +9.32% | -12.67% | +1.06% | +4.17% | -0.85% | -6.58% | -0.39% | -7.93% | -1.86% | +6.57% | +4.41% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |